Trial Profile
A Pilot Study to Evaluate the Efficacy of Ranolazine in Patients with Pulmonary Arterial Hypertension Associated With Heart Failure With Preserved Ejection Fraction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Ranolazine (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 08 Dec 2015 New trial record